Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 1 de 1
Filter
Add more filters










Database
Language
Publication year range
1.
J Biol Chem ; 283(40): 27144-53, 2008 Oct 03.
Article in English | MEDLINE | ID: mdl-18682396

ABSTRACT

The roles of the Pseudomonas aeruginosa-derived pigment pyocyanin (PYO) as an oxidant and activator of the proinflammatory transcription factor NF-kappaB were tested in a cystic fibrosis (CF) airway epithelial cell line, CF15. 100 microm PYO on its own had no effect or only small effects to activate NF-kappaB (<1.5-fold), but PYO synergized with the TLR5 agonist flagellin. Flagellin activated NF-kappaB 4-20-fold, and PYO increased these activations >2.5-fold. PYO could have synergized with flagellin to activate NF-kappaB by redox cycling with NADPH, generating superoxide (O(2)*), hydrogen peroxide (H(2)O(2)), and hydroxyl radical (HO*). Cytosol-targeted, redox-sensitive roGFP1 and imaging microscopy showed that 1-100 microm PYO oxidized CF15 cytosol redox potential (Psi(cyto)) from -325 mV (control) to -285 mV. O(2)* (derived from KO(2)*. or xanthine + xanthine oxidase) or H(2)O(2) oxidized Psi(cyto) dose-dependently but did not activate NF-kappaB, even in the presence of flagellin, and 400 microm H(2)O(2) inhibited NF-kappaB. Overexpressing intracellular catalase decreased effects of PYO and H(2)O(2) on Psi(cyto) but did not affect flagellin + PYO-activated NF-kappaB. Catalase also reversed the inhibitory effects of H(2)O(2) on NF-kappaB. The HO* scavenger DMSO did not alter the effects of PYO on Psi(cyto) and NF-kappaB. The synergistic NF-kappaB activation was calcium-independent. Thus, in the presence of flagellin, PYO activated NF-kappaB through a redox- and calcium-independent effect.


Subject(s)
Cystic Fibrosis/metabolism , NF-kappa B/metabolism , Oxidants/pharmacology , Pseudomonas aeruginosa , Pyocyanine/pharmacology , Respiratory Mucosa/metabolism , Catalase/biosynthesis , Catalase/genetics , Cell Line , Cystic Fibrosis/genetics , Cystic Fibrosis/pathology , Dimethyl Sulfoxide/pharmacology , Drug Synergism , Flagellin/agonists , Flagellin/pharmacology , Free Radical Scavengers/pharmacology , Humans , Hydrogen Peroxide/metabolism , NADP/genetics , NADP/metabolism , NF-kappa B/genetics , Oxidants/agonists , Oxidation-Reduction/drug effects , Pseudomonas aeruginosa/chemistry , Pyocyanine/agonists , Pyocyanine/chemistry , Respiratory Mucosa/pathology , Superoxides/metabolism , Toll-Like Receptor 5/agonists , Toll-Like Receptor 5/genetics , Toll-Like Receptor 5/metabolism , Xanthine/metabolism , Xanthine Oxidase/biosynthesis , Xanthine Oxidase/genetics
SELECTION OF CITATIONS
SEARCH DETAIL
...